Detalles de la búsqueda
1.
[Treat-all: challenges of partial response and low-level viremia].
Zhonghua Gan Zang Bing Za Zhi
; 31(3): 242-246, 2023 Mar 20.
Artículo
en Zh
| MEDLINE | ID: mdl-37137848
2.
[Ten-year changes in clinical characteristics and antiviral treatment patterns of chronic hepatitis B in China: a CR-HepB-based real-world study].
Zhonghua Gan Zang Bing Za Zhi
; 31(7): 698-704, 2023 Jul 20.
Artículo
en Zh
| MEDLINE | ID: mdl-37580251
3.
[Interpretation of the essential updates in guidelines for the prevention and treatment of chronic hepatitis B (Version 2022)].
Zhonghua Gan Zang Bing Za Zhi
; 31(4): 385-388, 2023 Apr 20.
Artículo
en Zh
| MEDLINE | ID: mdl-37248977
4.
[Multi-omics research contributes to early screening, diagnosis and treatment of liver cancer].
Zhonghua Gan Zang Bing Za Zhi
; 30(8): 793-796, 2022 Aug 20.
Artículo
en Zh
| MEDLINE | ID: mdl-36207934
5.
[Application of liquid biopsy in early screening and recurrence prediction of hepatocellular carcinoma].
Zhonghua Gan Zang Bing Za Zhi
; 30(8): 814-819, 2022 Aug 20.
Artículo
en Zh
| MEDLINE | ID: mdl-36207938
6.
[Clinical application of serum Golgi protein 73 in patients with chronic liver diseases].
Zhonghua Gan Zang Bing Za Zhi
; 30(1): 4-8, 2022 Jan 20.
Artículo
en Zh
| MEDLINE | ID: mdl-35152664
7.
[Establishing an integrated hospital-community pyramid for screening and achieving hepatocellular carcinoma early diagnosis and treatment].
Zhonghua Gan Zang Bing Za Zhi
; 29(4): 289-292, 2021 Apr 20.
Artículo
en Zh
| MEDLINE | ID: mdl-33979950
8.
[New progress in the diagnosis and treatment of hepatocellular carcinoma: a decade of grinding sword].
Zhonghua Gan Zang Bing Za Zhi
; 29(2): 111-115, 2021 Feb 20.
Artículo
en Zh
| MEDLINE | ID: mdl-33685077
9.
[A 2020 update on the progress of treatment and new drug clinical trials for hepatitis B].
Zhonghua Gan Zang Bing Za Zhi
; 29(2): 97-101, 2021 Feb 20.
Artículo
en Zh
| MEDLINE | ID: mdl-33685074
10.
[Clinical efficacy and safety analysis of camrelizumab combined with apatinib as a second-line therapy for unresectable hepatocellular carcinoma: a multicenter retrospective study].
Zhonghua Gan Zang Bing Za Zhi
; 29(4): 326-331, 2021 Apr 20.
Artículo
en Zh
| MEDLINE | ID: mdl-33979958
11.
[Application of aMAP score to assess the risk of hepatocarciongenesis in population of chronic liver disease in primary hospitals].
Zhonghua Gan Zang Bing Za Zhi
; 29(4): 332-337, 2021 Apr 20.
Artículo
en Zh
| MEDLINE | ID: mdl-33979959
12.
[Clinical cure of hepatitis B: consensus and controversy].
Zhonghua Gan Zang Bing Za Zhi
; 28(8): 636-639, 2020 Aug 20.
Artículo
en Zh
| MEDLINE | ID: mdl-32911898
13.
[Clinical considerations in the design of clinical trial for innovative hepatitis B drugs].
Zhonghua Gan Zang Bing Za Zhi
; 28(8): 654-657, 2020 Aug 20.
Artículo
en Zh
| MEDLINE | ID: mdl-32911902
14.
[Promoting thorough action for early screening, diagnosis and treatment of liver cancer].
Zhonghua Gan Zang Bing Za Zhi
; 27(11): 817-821, 2019 Nov 20.
Artículo
en Zh
| MEDLINE | ID: mdl-31941233
15.
[Action for shield project promoting zero mother-to-child transmission of hepatitis B virus].
Zhonghua Gan Zang Bing Za Zhi
; 27(2): 81-84, 2019 Feb 20.
Artículo
en Zh
| MEDLINE | ID: mdl-30818908
16.
[Organizing an assembly to eliminate hepatitis B virus through a project zero mother-to-child transmission of hepatitis B virus].
Zhonghua Gan Zang Bing Za Zhi
; 27(2): 102-105, 2019 Feb 20.
Artículo
en Zh
| MEDLINE | ID: mdl-30818913
17.
[Prevalence and risk factors of nonalcoholic fatty liver disease in patients with chronic hepatitis B receiving antiviral therapy].
Zhonghua Gan Zang Bing Za Zhi
; 27(5): 347-351, 2019 May 20.
Artículo
en Zh
| MEDLINE | ID: mdl-31177658
18.
[A phase II, single-arm, open-label, multicenter clinical study to evaluate the efficacy and safety of sofosbuvir combined with ribavirin in patients with genotype 2 chronic hepatitis C virus infection].
Zhonghua Gan Zang Bing Za Zhi
; 27(5): 352-357, 2019 May 20.
Artículo
en Zh
| MEDLINE | ID: mdl-31177659
19.
Prevalence of pathogenicity island ETT2 in Escherichia coli isolated from piglets with diarrhea in northeast of China.
Pol J Vet Sci
; 21(1): 5-12, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-29623998
20.
[Selection of direct-acting antiviral agents for chronic hepatitis C infection].
Zhonghua Gan Zang Bing Za Zhi
; 26(3): 169-172, 2018 Mar 20.
Artículo
en Zh
| MEDLINE | ID: mdl-29804388